DiaMedica Therapeutics Earning Date (DMAC)

USA |NASDAQ |USD

DMAC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 9, 2022 Jun 2022 $-0.23 $-0.13 $-0.17
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 9, 2022 Jun 2022 $0.00 - $0.00

Diamedica Therapeutics's next earnings date is Tuesday, Aug 9, 2022 for the fiscal quarter ending Jun 2022.

DMAC Earnings Date & History Chart

DMAC Earnings & Revenue Forecast

DMAC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 3 $-0.23 $-0.32 $-0.17
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $-0.96 $-1.26 $-0.81
Dec 2023 2 $-0.89 $-0.89 $-0.89

DMAC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 1 / 0 $-0.25 $-0.25 $-0.27
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 3 / 0 $-1.01 $-1.01 $-1.01
Dec 2023 0 / 0 $-0.91 $-0.91 $-0.96

DMAC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 2 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $0.00 $0.00 $0.00
Dec 2023 2 $0.00 $0.00 $0.00

DMAC Earnings Date & Revenue History

DMAC Earnings History

|
Show More
Show More

DMAC Revenue History

|
Show More
Show More

Diamedica Therapeutics Next Earnings Date & Report

DMAC Next Earnings Date & Report Preview: Jun 2022 (FQ)

DMAC's next earnings date is Tuesday, Aug 9, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Diamedica Therapeutics's next quarterly earnings is $-0.23, with a low EPS estimation of $-0.32, and a high estimation of $-0.17.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.25, the last 2 month trend is $-0.25, and the 3 month trend is $-0.27.

Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Diamedica Therapeutics Previous Earnings Dates & Reports

DMAC Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Diamedica Therapeutics's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

DMAC's earnings per share (EPS) was $-0.13, beating the consensus analysts forecast of $-0.21 by 38.10%.

The EPS was lower than the previous fiscal quarter (Dec 2021) by 30.00%, and higher than the same period a year before (Mar 2021) by -31.58%.

The company reported a net income of $-3.51B.

Free cash flow for the quarter was $-3.89M , compared to $-2.81M last quarter and $-4.32M a year before.

DMAC ended the quarter with $43.00K in total debt, a decrease of -17.31% compared to the previous quarter, and a decrease of -57.84% compared to the same quarter a year before.

DMAC Previous Earnings Date & Report Recap: Dec 2021 (FY)

Diamedica Therapeutics's previous annual earnings date was Mar 14, 2022 for its fiscal year ended Dec 31, 2021.

DMAC's earnings per share (EPS) was $-0.64, beating the consensus analysts forecast of $-0.73 by -12.33% , and higher than the previous year's EPS (Dec 2020) by -17.95%.

Revenues were $0.00.

The company reported a net income of $-13.59M.

Diamedica Therapeutics reported a free cash flow of $-12.27M for its fiscal year, compared to $-9.23M a year ago.

The company ended the fiscal year with $52.00K in total debt, a decrease of -27.78% compared to the previous year.